Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.22−0.28 (-6.22%)
Close on Nov 20, 2026Market cap $52.99MP/E –Yield –
Neuraxis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Neuraxis's revenue for the twelve months ending Jun 30, 2026 was $5.32M, up 65.2% year over year. For fiscal 2025 it was $3.57M, up 32.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.57M | +32.9% |
| FY2024 | Dec 31, 2024 | $2.69M | +9.2% |
| FY2023 | Dec 31, 2023 | $2.46M | -8.4% |
| FY2022 | Dec 31, 2022 | $2.68M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.93M | +115.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.61M | +79.5% |
| Q4 FY2025 | Dec 31, 2025 | $968.13K | +27.2% |
| Q3 FY2025 | Sep 30, 2025 | $811.41K | +21.7% |
| Q2 FY2025 | Jun 30, 2025 | $894.09K | +46.2% |
| Q1 FY2025 | Mar 31, 2025 | $895.66K | +38.5% |
| Q4 FY2024 | Dec 31, 2024 | $761.17K | +43.2% |
| Q3 FY2024 | Sep 30, 2024 | $666.63K | +39.6% |
| Q2 FY2024 | Jun 30, 2024 | $611.50K | -5.3% |
| Q1 FY2024 | Mar 31, 2024 | $646.64K | -19.7% |
| Q4 FY2023 | Dec 31, 2023 | $531.46K | -13.3% |
| Q3 FY2023 | Sep 30, 2023 | $477.46K | -22.8% |
| Q2 FY2023 | Jun 30, 2023 | $646.02K | -5.4% |
| Q1 FY2023 | Mar 31, 2023 | $805.11K | – |
| Q4 FY2022 | Dec 31, 2022 | $613.08K | – |
| Q3 FY2022 | Sep 30, 2022 | $618.81K | – |
| Q2 FY2022 | Jun 30, 2022 | $682.58K | – |
See a number that looks wrong?